Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
Explainable machine learning prediction of functional independence measure scores and gain in subacute stroke survivors.
Journal: Journal of neuroengineering and rehabilitation
Published: November 12, 2025
Biomarker study of pembrolizumab in patients with advanced rare cancers.
Journal: Cell reports. Medicine
Published: September 24, 2025
Editor's Note: Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
Journal: Cancer discovery
Published: September 17, 2025
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy.
Journal: JAMA network open
Published: April 07, 2025
Conjunctival melanoma genomic analysis reveals intermediate tumor mutation burden and genomic overlap with cutaneous melanoma.
Journal: NPJ precision oncology
Published: February 19, 2025
Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 21, 2024
Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study.
Journal: Oral oncology
Published: February 26, 2024
Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial.
Journal: Nature communications
Published: February 14, 2024
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma.
Journal: Cancer research communications
Published: January 10, 2024
Last Updated: 09/26/2026